The downwards trendline is showing signs of cracks and buying on weakness presents an excellent risk reward opportunity on HTBX that has just filed a patent application for a lung cancer inhibitor.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
